Loading...
XNASSHOTW
Market cap3mUSD
Jan 07, Last price  
0.10USD
1D
-23.08%
1Q
-50.00%
IPO
-68.25%
Name

Jupiter Wellness Inc

Chart & Performance

D1W1MN
XNAS:SHOTW chart
P/E
P/S
0.52
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
221.62%
Revenues
6m
+115.44%
6,4551,065,6652,876,2736,196,743
Net income
-18m
L-40.77%
-932,019-6,406,007-29,836,351-17,671,484
CFO
-6m
L-15.48%
-692,740-2,732,736-7,567,645-6,395,942
Earnings
Mar 31, 2025

Profile

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
IPO date
Oct 22, 2020
Employees
10
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑12
Income
Revenues
6,197
115.44%
Cost of revenue
17,687
Unusual Expense (Income)
NOPBT
(11,490)
NOPBT Margin
Operating Taxes
2,448
Tax Rate
NOPAT
(13,938)
Net income
(17,671)
-40.77%
Dividends
Dividend yield
Proceeds from repurchase of equity
(2,603)
BB yield
Debt
Debt current
2,212
Long-term debt
1,203
Deferred revenue
Other long-term liabilities
Net debt
(1,433)
Cash flow
Cash from operating activities
(6,396)
CAPEX
(15)
Cash from investing activities
(2,472)
Cash from financing activities
(956)
FCF
(16,699)
Balance
Cash
4,848
Long term investments
Excess cash
4,539
Stockholders' equity
(50,575)
Invested Capital
56,972
ROIC
ROCE
EV
Common stock shares outstanding
22,107
Price
Market cap
EV
EBITDA
(10,969)
EV/EBITDA
Interest
1,286
Interest/NOPBT